|
||
|
||
|
 |
|
|
 1895-1965 | 1968-1985 | 1987-1993 | 1994-1998 | 1999-Present 1994 DePuy's parent company, Corange Ltd., purchases ACE Medical Company, now known as DePuy ACE Medical Company, a manufacturer of orthopaedic trauma products in the U.S., and the number two supplier of trauma products in Japan. Tidmore becomes president of DePuy Inc. R. Michael McCaffrey moves to the newly appointed president of DePuy Motech. 1996 DePuy acquires the former Orthopedic Technology, Inc., which expanded its sports medicine business. Now known as DePuy OrthoTech, the company manufactures and markets arthroscopy instruments, tissue fixation devices, braces, ankle supports and soft goods. Corange, DePuy's parent company, announced the initial public offering of 14,780, 000 shares of common stock at a price of $17.50 per share. Following the offering, Corange and its subsidiaries will continue to own approximately 84.8 percent of the common stock of DePuy, Inc. Michael Dormer is appointed president and chief operating officer of DePuy Inc., with James Lent continuing as CEO and Chairman. William Tidmore accepts the presidency of DePuy Motech, while R. Michael McCaffrey is named president of DePuy Development Corporation. James Taylor assumes the role of president of DePuy International Ltd, in Leeds, England. Robert Morel becomes president of DePuy ACE. DePuy Inc. changes its name to DePuy Orthopaedics, Inc. 1997 DePuy, Inc. and the Landanger family sign an agreement for DePuy to purchase 1,939,453 shares in Landanger-Camus held by the Landanger family and certain minority shareholders, which represents 89.6% of the shares outstanding. Landanger-Camus is the leading French manufacturer of hip implants and one of the leading distributors of orthopaedic devices and supplies. Roche enters into an agreement with the owners of Corange Ltd., Bermuda, to purchase all shares in Corange. Corange Ltd. is sole owner of the diagnostics and pharmaceuticals business of the Boehringer Mannheim Group. Corange also holds 84.2% of the shares in DePuy, Inc. The value of the transaction is expected to be around 11 billion US dollars. Peter Wehrly is appointed executive vice president of DePuy OrthoTech, and later promoted to president. 1998 Roche officially becomes the parent company of DePuy and Boehringer Mannheim. DePuy purchases Cleveland-based AcroMed, the second largest spinal company. This acquisition makes DePuy Motech the second largest spinal company. Johnson & Johnson acquires DePuy. 1895-1965 | 1968-1985 | 1987-1993 | 1994-1998 | 1999-Present |
|||||||||||||||||||||||||||||||||||||||||||||||||
 |
||||
|
||||
